Summary

The global physiotherapy equipment market size is projected to reach USD 8.37 billion by 2031 from USD 6.11 billion in 2026, at a CAGR of 6.5% during the forecast period. Lifestyle factors, such as lack of exercise and poor dieting, compounded by an aging population, explain the growth of chronic illnesses like arthritis and cardiovascular diseases. The rehabilitation requirements increase correspondingly. Concomitantly, the increased number of rehabilitation requirements leads to an upsurge in demand for physiotherapy equipment for managing older people's mobility and pain relief. The market is also driven by several other factors, such as technological advancements, rising R&D spending, increased awareness, the need for personalized physiotherapy equipment, and economic expansion in emerging countries. The electrotherapy segment is expected to dominate the market. Electrotherapy is one of the most widely adopted modalities in physiotherapy for pain management, muscle rehabilitation, and functional recovery across musculoskeletal and neurological conditions. Common electrotherapy techniques include Transcutaneous Electrical Nerve Stimulation (TENS), Interferential Therapy (IFT), Electrical Muscle Stimulation (EMS), Percutaneous Electrical Nerve Stimulation (PENS), and Therapeutic Ultrasound. These modalities provide non-invasive treatment options that help relieve acute and chronic pain, accelerate the healing of musculoskeletal injuries, improve blood circulation, promote wound healing, reduce inflammation, and relax muscle spasms, with minimal side effects. Technological advancements have further enhanced treatment efficacy through the development of compact, portable, and digitally connected electrotherapy devices, enabling both clinical and home-based rehabilitation. Furthermore, the growing availability of programmable treatment protocols and personalized therapy settings has improved patient adherence, convenience, and overall rehabilitation outcomes, supporting the increasing adoption of electrotherapy equipment across healthcare settings. Musculoskeletal & orthopedic rehabilitation segment accounted for the largest share of the applications market in 2025. Musculoskeletal and orthopedic rehabilitation plays a vital role in the treatment and recovery of conditions such as ligament sprains, muscle strains, osteoarthritis, fractures, spinal disorders, cartilage injuries, joint replacements, and other pre- and post-operative orthopedic conditions. The increasing burden of musculoskeletal and orthopedic disorders is driven by a rapidly aging population, rising participation in sports and recreational activities, sedentary lifestyles, increasing obesity rates, and repetitive occupational strain. Furthermore, the growing incidence of road traffic accidents, workplace injuries, and trauma-related musculoskeletal conditions has accelerated the demand for rehabilitation services. As healthcare providers increasingly emphasize early intervention, functional recovery, and improved mobility, the adoption of advanced physiotherapy equipment across hospitals, rehabilitation centers, outpatient clinics, and home care settings continues to expand, supporting enhanced clinical outcomes and reducing long-term disability. The Asia Pacific is estimated to register the highest CAGR during the forecast period. The physiotherapy equipment market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa. The Asia Pacific is projected to register the highest CAGR during the forecast period. The region's growth is primarily driven by its rapidly aging population, increasing incidence of musculoskeletal disorders, stroke, and sports injuries, and rising awareness regarding early rehabilitation and physiotherapy. In addition, expanding healthcare infrastructure, increasing healthcare expenditure, improving access to rehabilitation services, and favorable government initiatives in countries such as China, India, Japan, South Korea, and Australia are accelerating the adoption of advanced physiotherapy equipment. The growing number of rehabilitation centers, coupled with increasing investments by both public and private healthcare providers, is expected to further drive market growth across the region. The break-up of the profile of primary participants in the physiotherapy equipment market: • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 – 30% • By Designation: C-level - 27%, D-level - 18%, and Others - 55% • By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and Middle East & Africa- 4% The prominent players operating in the physiotherapy equipment market are Enovis Corp. (US), BTL Industries (UK), Performance Health (US), ITO Co., Ltd. (Japan), Enraf-Nonius B.V. (Netherlands), Dynatronics Corporation (US), Mectronic Medicale (Italy), Zimmer MedizinSysteme GmbH (Germany), Altivera Medical, Inc. (formerly Zynex Inc.) (US), Tactile Medical (US), Technogym SpA (Italy), Richmar (US), Storz Medical AG (Germany), DIH Medical (Switzerland), OG Wellness Technologies Co., Ltd. (Japan), Gymna (Belgium), Omron Corporation (Japan), Physiomed Elektromedizin AG (Germany), Guangzhou Longest Science&Technology Co., Ltd. (China), Astar (Poland), KINVENT (France), ExoAtlet (Luxembourg), ManaMed (US), BeAble Health Pvt. Ltd. (India), and Balance Metrix (Australia). Research Coverage This report examines the physiotherapy equipment market by product, application, end-user, and region. The report also analyses factors (such as drivers, restraints, opportunities and challenges) affecting market growth. It evaluates the market opportunities and challenges for stakeholders and provides details on the competitive landscape for market leaders. The report also examines micro-markets in terms of their growth trends, prospects, and contributions to the total physiotherapy equipment market. The report forecasts revenue for the market segments across five major regions. Reasons to Buy the Report The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall physiotherapy equipment market and the subsegments. This report will help stakeholders understand the competitive landscape and gain insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. This report provides insights into the following pointers: • Analysis of key drivers (rapid aging, technological advancements), restraints (unstable reimbursement scenario), challenges (alternate therapies), and opportunities (rise in home healthcare services) • Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, in the physiotherapy equipment Market. • Market Development: Comprehensive information on the lucrative emerging markets by products, applications, end users, and region. • Market Diversification: Exhaustive information about the growing geographies, recent developments, and investments in the physiotherapy equipment market. • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global physiotherapy equipment market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.3 STUDY SCOPE 30
1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION 30
1.3.2 INCLUSIONS & EXCLUSIONS 31
1.3.3 YEARS CONSIDERED 31
1.4 CURRENCY CONSIDERED 32
1.5 STAKEHOLDERS 32
1.6 SUMMARY OF CHANGES 33
2 EXECUTIVE SUMMARY 34
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 34
2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS 35
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH 36
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 37
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 38
3 PREMIUM INSIGHTS 39
3.1 OPPORTUNITIES FOR PLAYERS IN PHYSIOTHERAPY EQUIPMENT MARKET 39
3.2 ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET,
BY END USER AND COUNTRY (2025) 40
3.3 PHYSIOTHERAPY EQUIPMENT MARKET: KEY COUNTRIES 41
3.4 PHYSIOTHERAPY EQUIPMENT MARKET, BY REGION (2026−2031) 42
3.5 PHYSIOTHERAPY EQUIPMENT MARKET: DEVELOPED VS. EMERGING MARKETS 42
4 MARKET OVERVIEW 43
4.1 INTRODUCTION 43
4.2 MARKET DYNAMICS 43
4.2.1 DRIVERS 44
4.2.1.1 Rapidly growing geriatric population and increasing incidence of chronic diseases 44
4.2.1.2 Growing incidence of sports injuries, degenerative joint disorders, and cerebrovascular diseases 45
4.2.1.3 Rising demand for rehabilitation care 45
4.2.1.4 Growing demand for home-based and telerehabilitation care 46
4.2.2 RESTRAINTS 46
4.2.2.1 Unstable reimbursement scenario for physiotherapy 46
4.2.2.2 Direct access to physiotherapy 47
4.2.3 OPPORTUNITIES 47
4.2.3.1 Emerging markets 47
4.2.3.2 Rising technological advancements 48
4.2.4 CHALLENGES 49
4.2.4.1 Shortage of skilled personnel 49
4.2.4.2 Alternate therapies such as acupuncture 49
4.3 UNMET NEEDS & WHITE SPACES 50
4.3.1 UNMET NEEDS IN PHYSIOTHERAPY EQUIPMENT MARKET 50
4.3.2 WHITE SPACE OPPORTUNITIES 50
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 51
4.4.1 INTERCONNECTED MARKETS 51
4.4.2 CROSS-SECTOR OPPORTUNITIES 52
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 53
5 INDUSTRY TRENDS 54
5.1 PORTER’S FIVE FORCES ANALYSIS 54
5.1.1 THREAT OF NEW ENTRANTS 55
5.1.2 THREAT OF SUBSTITUTES 55
5.1.3 BARGAINING POWER OF SUPPLIERS 55
5.1.4 BARGAINING POWER OF BUYERS 55
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 55
5.2 MACROECONOMIC OUTLOOK 56
5.2.1 INTRODUCTION 56
5.2.2 GDP TRENDS & FORECAST 56
5.2.3 TRENDS IN REHABILITATION EQUIPMENT INDUSTRY 58
5.3 SUPPLY CHAIN ANALYSIS 59
5.4 VALUE CHAIN ANALYSIS 60
5.5 ECOSYSTEM ANALYSIS 61
5.5.1 ROLE IN ECOSYSTEM 62
5.6 PRICING ANALYSIS 63
5.6.1 AVERAGE SELLING PRICE OF PHYSIOTHERAPY EQUIPMENT,
BY PRODUCT, 2025 63
5.6.2 AVERAGE SELLING PRICE OF PHYSIOTHERAPY EQUIPMENT,
BY REGION, 2023–2025 64
5.7 TRADE ANALYSIS 65
5.7.1 IMPORT DATA FOR PHYSIOTHERAPY EQUIPMENT (HS CODE: 9019),
2021–2025 65
5.7.2 EXPORT DATA FOR PHYSIOTHERAPY EQUIPMENT (HS CODE: 9019),
2021–2025 66
5.8 KEY CONFERENCES & EVENTS, 2026–2027 66
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 67
5.10 CASE STUDY ANALYSIS 68
5.10.1 CASE STUDY 1: STARTOON LABS RECEIVED USFDA APPROVAL FOR PHEEZEE PHYSIOTHERAPY DEVICE 68
5.10.2 CASE STUDY 2: NHS IN THE UK TO LAUNCH AI-DRIVEN PHYSIOTHERAPY CLINIC 69
5.10.3 CASE STUDY 3: BURJEEL AND LEEJAM LAUNCH PHYSIOTHERABIA CENTERS IN RIYADH 69
5.11 INVESTMENT & FUNDING SCENARIO 70
5.12 IMPACT OF 2025 US TARIFFS ON PHYSIOTHERAPY EQUIPMENT MARKET 70
5.12.1 INTRODUCTION 70
5.12.2 KEY TARIFF RATES 71
5.12.3 PRICE IMPACT ANALYSIS 72
5.12.4 IMPACT ON REGION 72
5.12.4.1 US 72
5.12.4.2 Europe 73
5.12.4.3 Asia Pacific 73
5.12.5 IMPACT ON END-USE INDUSTRIES 73
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS,
AND INNOVATIONS 74
6.1 KEY EMERGING TECHNOLOGIES 74
6.2 COMPLEMENTARY TECHNOLOGIES 74
6.2.1 AUGMENTED REALITY (AR) 74
6.3 TECHNOLOGY/PRODUCT ROADMAP 75
6.3.1 SHORT-TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION 75
6.3.2 MID-TERM (2027–2030) | EXPANSION & STANDARDIZATION 75
6.3.3 LONG-TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION 76
6.4 PATENT ANALYSIS 77
6.4.1 PATENT PUBLICATION TRENDS FOR PHYSIOTHERAPY EQUIPMENT MARKET 77
6.4.2 TOP APPLICANTS (COMPANIES) OF PHYSIOTHERAPY EQUIPMENT PATENTS 77
6.4.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN PHYSIOTHERAPY EQUIPMENT MARKET 78
6.4.4 LIST OF MAJOR PATENTS 78
6.5 IMPACT OF AI/GEN AI ON PHYSIOTHERAPY EQUIPMENT MARKET 79
6.5.1 TOP USE CASES & MARKET POTENTIAL 80
6.5.2 TOP CASE STUDIES OF AI IMPLEMENTATION IN PHYSIOTHERAPY EQUIPMENT MARKET 81
6.5.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS 82
6.5.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PHYSIOTHERAPY EQUIPMENT MARKET 83
6.6 SUCCESS STORIES & REAL-WORLD APPLICATIONS 84
6.6.1 DIH MEDICAL/HOCOMA: LOKOMAT (ROBOT-ASSISTED GAIT REHABILITATION) 84
6.6.2 BTL INDUSTRIES: EMSELLA (NON-INVASIVE PELVIC FLOOR REHABILITATION) 84
6.6.3 STORZ MEDICAL: DUOLITH SD1 “ULTRA”(COMBINED SHOCKWAVE THERAPY IN SPORTS REHABILITATION) 84
7 SUSTAINABILITY & REGULATORY LANDSCAPE 85
7.1 REGIONAL REGULATIONS & COMPLIANCE 85
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
7.1.2 INDUSTRY STANDARDS 86
7.1.2.1 North America 86
7.1.2.1.1 US 86
7.1.2.1.2 Canada 86
7.1.2.2 Europe 87
7.1.2.3 Asia Pacific 87
7.1.2.3.1 Japan 87
7.1.2.3.2 China 88
7.1.2.3.3 India 88
7.2 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 89
7.2.1 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN PHYSIOTHERAPY EQUIPMENT 89
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 90
8.1 DECISION-MAKING PROCESS 90
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 90
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 91
8.2.2 KEY BUYING CRITERIA 91
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 92
8.4 UNMET NEEDS IN END USERS 94
8.5 MARKET PROFITABILITY 95
8.5.1 REVENUE POTENTIAL 95
8.5.2 COST DYNAMICS 95
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 95
9 PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT 96
9.1 INTRODUCTION 97
9.2 EQUIPMENT 97
9.2.1 ELECTROTHERAPY EQUIPMENT 98
9.2.1.1 Rising demand for non-pharmacological pain-management options to drive market growth 98
9.2.2 ULTRASOUND EQUIPMENT 101
9.2.2.1 High prevalence of musculoskeletal disorders and sports injuries and growing postoperative rehabilitation needs to boost growth 101
9.2.3 EXERCISE THERAPY EQUIPMENT 104
9.2.3.1 Shift toward active, function-oriented rehabilitation and growing emphasis on measurable clinical outcomes to fuel market growth 104
9.2.4 HEAT THERAPY EQUIPMENT 106
9.2.4.1 Expansion of outpatient rehabilitation and availability of portable products for supervised home use to drive growth 106
9.2.5 CRYOTHERAPY EQUIPMENT 109
9.2.5.1 Increasing orthopedic procedure volumes to support market growth 109
9.2.6 COMBINATION THERAPY EQUIPMENT 112
9.2.6.1 Ability of combination systems to consolidate capital purchases and improve clinical workflow to drive demand 112
9.2.7 CONTINUOUS PASSIVE MOTION THERAPY EQUIPMENT 114
9.2.7.1 Ability to maintain passive joint mobility and reduce adverse effects of prolonged immobilization to fuel market 114
9.2.8 SHOCKWAVE THERAPY EQUIPMENT 116
9.2.8.1 Availability of compact radial systems suitable for physiotherapy and sports medicine clinics to boost demand 116
9.2.9 LASER THERAPY EQUIPMENT 119
9.2.9.1 Ability of higher-power systems to treat larger areas within shorter sessions to fuel growth 119
9.2.10 TRACTION THERAPY EQUIPMENT 122
9.2.10.1 Availability of programmable clinic-based and portable home-use devices to support growth 122
9.2.11 MAGNETIC PRESSURE THERAPY EQUIPMENT 125
9.2.11.1 Introduction of higher-intensity systems capable of stimulating deeper tissues without direct skin contact to drive adoption 125
9.2.12 OTHER PHYSIOTHERAPY EQUIPMENT 128
9.3 ACCESSORIES 130
9.3.1 PHYSIOTHERAPY FURNITURE 131
9.3.1.1 Growing use for physical therapy, rehab, occupational therapy, sports medicine, and chiropractic medicine to drive market 131
9.3.2 OTHER ACCESSORIES 132
10 PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION 133
10.1 INTRODUCTION 134
10.2 MUSCULOSKELETAL & ORTHOPEDIC REHABILITATION 134
10.2.1 RISING INCIDENCE OF MUSCULOSKELETAL DISORDERS TO DRIVE DEMAND 134
10.3 NEUROLOGICAL REHABILITATION 136
10.3.1 SIGNIFICANT UNMET REHABILITATION NEEDS, PARTICULARLY IN EMERGING ECONOMIES, TO CREATE LONG-TERM MARKET OPPORTUNITY 136
10.4 CARDIOVASCULAR & PULMONARY REHABILITATION 138
10.4.1 GROWING CARDIOVASCULAR AND RESPIRATORY DISEASE BURDEN TO DRIVE DEMAND FOR EXERCISE THERAPY EQUIPMENT 138
10.5 SPORTS REHABILITATION 139
10.5.1 DEMAND FOR STRUCTURED REHABILITATION AND OBJECTIVE RETURN-TO-PLAY ASSESSMENTS TO BOOST MARKET 139
10.6 PELVIC HEALTH & UROGYNECOLOGICAL REHABILITATION 141
10.6.1 SHIFT TOWARD OUTPATIENT, HOME-BASED, AND REMOTELY MONITORED PELVIC-HEALTH PROGRAMS TO EXPAND ADDRESSABLE EQUIPMENT BASE 141
10.7 OTHER APPLICATIONS 142
11 PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER 144
11.1 INTRODUCTION 145
11.2 PHYSIOTHERAPY & REHABILITATION CENTERS 145
11.2.1 RISING INCIDENCE OF SPORTS INJURIES AND DISABILITIES TO DRIVE SEGMENT 145
11.3 HOSPITALS 146
11.3.1 GROWING PATIENT VOLUMES AT HOSPITALS TO DRIVE DEMAND 146
11.4 HOME CARE SETTINGS 148
11.4.1 RISING DEMAND FOR HOME CARE TO DRIVE DEMAND 148
11.5 PHYSICIANS’ OFFICES 149
11.5.1 COST-SAVING POTENTIAL AND QUALITY OF CARE PROVIDED IN PHYSICIANS’ OFFICES TO DRIVE GROWTH 149
11.6 OTHER END USERS 151
12 PHYSIOTHERAPY EQUIPMENT MARKET, BY REGION 152
12.1 INTRODUCTION 153
12.2 NORTH AMERICA 154
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 155
12.2.2 US 158
12.2.2.1 US to dominate North American market during forecast period 158
12.2.3 CANADA 161
12.2.3.1 Growing penetration of preventive care services to boost market 161
12.3 EUROPE 164
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 164
12.3.2 GERMANY 167
12.3.2.1 Rising geriatric population and increase in chronic conditions to drive demand 167
12.3.3 UK 170
12.3.3.1 Wide acceptance of physical therapy to increase adoption of physiotherapy equipment 170
12.3.4 FRANCE 172
12.3.4.1 Rising healthcare expenditure and favorable reimbursement scenario to drive market 172
12.3.5 ITALY 175
12.3.5.1 Increasing incidence of fall injuries and orthopedic disorders to drive market 175
12.3.6 SPAIN 177
12.3.6.1 Rising geriatric population to drive adoption of physiotherapy equipment 177
12.3.7 REST OF EUROPE 180
12.4 ASIA PACIFIC 182
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 182
12.4.2 JAPAN 185
12.4.2.1 Large geriatric population to drive adoption of physiotherapy equipment 185
12.4.3 CHINA 188
12.4.3.1 Global manufacturing hub for physiotherapy and rehabilitation equipment to drive market 188
12.4.4 INDIA 190
12.4.4.1 Expansion of new acute care settings to drive demand 190
12.4.5 AUSTRALIA 193
12.4.5.1 Growing population and rising cases of chronic musculoskeletal conditions to drive market 193
12.4.6 SOUTH KOREA 195
12.4.6.1 Fast-growing aging population and rising medical tourism to drive market 195
12.4.7 REST OF ASIA PACIFIC 198
12.5 LATIN AMERICA 200
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 204
12.5.2 BRAZIL 204
12.5.2.1 Rapidly aging population and expanding healthcare infrastructure to augment market growth 204
12.5.3 MEXICO 206
12.5.3.1 Advancements in healthcare infrastructure to drive market 206
12.5.4 ARGENTINA 209
12.5.4.1 Advancements in healthcare infrastructure to drive market 209
12.5.5 REST OF LATIN AMERICA 211
12.6 MIDDLE EAST & AFRICA 213
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 213
12.6.2 GCC COUNTRIES 217
12.6.2.1 Robust healthcare industry to drive market 217
12.6.3 REST OF MIDDLE EAST & AFRICA 219
13 COMPETITIVE LANDSCAPE 222
13.1 OVERVIEW 222
13.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN 222
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHYSIOTHERAPY EQUIPMENT MARKET 223
13.3 REVENUE ANALYSIS, 2021–2025 224
13.4 MARKET RANKING ANALYSIS 225
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS 227
13.5.1 STARS 227
13.5.2 EMERGING LEADERS 227
13.5.3 PERVASIVE PLAYERS 227
13.5.4 PARTICIPANTS 228
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 229
13.5.5.1 Company footprint 229
13.5.5.2 Region footprint 230
13.5.5.3 Product footprint 231
13.5.5.4 Application footprint 232
13.5.5.5 End-user footprint 233
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 234
13.6.1 PROGRESSIVE COMPANIES 234
13.6.2 RESPONSIVE COMPANIES 234
13.6.3 DYNAMIC COMPANIES 234
13.6.4 STARTING BLOCKS 234
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 236
13.6.5.1 List of key startups/SMEs 236
13.6.5.2 Competitive benchmarking of key startups/SMEs 236
13.7 BRAND/PRODUCT COMPARISON 237
13.8 COMPANY VALUATION & FINANCIAL METRICS 238
13.8.1 FINANCIAL METRICS 238
13.8.2 COMPANY VALUATION 238
13.9 COMPETITIVE SCENARIO 239
13.9.1 PRODUCT LAUNCHES & APPROVALS 239
13.9.2 DEALS 240
13.9.3 EXPANSIONS 243
13.9.4 OTHER DEVELOPMENTS 244
14 COMPANY PROFILES 245
14.1 KEY PLAYERS 245
14.1.1 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION) 245
14.1.1.1 Business overview 245
14.1.1.2 Products offered 246
14.1.1.3 Recent developments 251
14.1.1.3.1 Product launches 251
14.1.1.3.2 Deals 252
14.1.1.3.3 Expansions 253
14.1.1.3.4 Other developments 253
14.1.1.4 MnM view 254
14.1.1.4.1 Right to win 254
14.1.1.4.2 Strategic choices 254
14.1.1.4.3 Weaknesses & competitive threats 254
14.1.2 ZIMMER MEDIZINSYSTEME GMBH 255
14.1.2.1 Business overview 255
14.1.2.2 Products offered 255
14.1.2.3 Recent developments 256
14.1.2.3.1 Product launches 256
14.1.2.3.2 Deals 257
14.1.2.3.3 Other developments 257
14.1.2.4 MnM view 258
14.1.2.4.1 Right to win 258
14.1.2.4.2 Strategic choices 258
14.1.2.4.3 Weaknesses & competitive threats 258
14.1.3 ALTIVERA MEDICAL, INC. (FORMERLY ZYNEX, INC.) 259
14.1.3.1 Business overview 259
14.1.3.2 Products offered 260
14.1.3.3 Recent developments 261
14.1.3.3.1 Product launches & approvals 261
14.1.3.3.2 Deals 262
14.1.3.3.3 Expansions 263
14.1.3.3.4 Other developments 263
14.1.3.4 MnM view 264
14.1.3.4.1 Right to win 264
14.1.3.4.2 Strategic choices 264
14.1.3.4.3 Weaknesses & competitive threats 264
14.1.4 PERFORMANCE HEALTH (SUBSIDIARY OF MADISON DEARBORN PARTNERS) 265
14.1.4.1 Business overview 265
14.1.4.2 Products offered 265
14.1.4.3 Recent developments 272
14.1.4.3.1 Product launches 272
14.1.4.3.2 Deals 273
14.1.4.3.3 Other developments 274
14.1.4.4 MnM view 274
14.1.4.4.1 Right to win 274
14.1.4.4.2 Strategic choices 275
14.1.4.4.3 Weaknesses & competitive threats 275
14.1.5 ITO CO., LTD. 276
14.1.5.1 Business overview 276
14.1.5.2 Products offered 276
14.1.5.3 MnM view 278
14.1.5.3.1 Right to win 278
14.1.5.3.2 Strategic choices 278
14.1.5.3.3 Weaknesses & competitive threats 278
14.1.6 DYNATRONICS CORPORATION 279
14.1.6.1 Business overview 279
14.1.6.2 Products offered 280
14.1.6.3 Recent developments 282
14.1.6.3.1 Product launches 282
14.1.6.3.2 Deals 283
14.1.6.3.3 Other developments 283
14.1.7 BTL INDUSTRIES 284
14.1.7.1 Business overview 284
14.1.7.2 Products offered 284
14.1.7.3 Recent developments 286
14.1.7.3.1 Product launches 286
14.1.7.3.2 Deals 286
14.1.7.3.3 Expansions 287
14.1.7.3.4 Other developments 287
14.1.8 ENRAF-NONIUS B.V. 288
14.1.8.1 Business overview 288
14.1.8.2 Products offered 288
14.1.8.3 Recent developments 290
14.1.8.3.1 Deals 290
14.1.9 MECTRONIC MEDICALE 291
14.1.9.1 Business overview 291
14.1.9.2 Products offered 291
14.1.10 RICHMAR (SUBSIDIARY OF DRIVE MEDICAL) 293
14.1.10.1 Business overview 293
14.1.10.2 Products offered 293
14.1.10.3 Recent developments 295
14.1.10.3.1 Product launches 295
14.1.10.3.2 Deals 296
14.1.11 STORZ MEDICAL AG 297
14.1.11.1 Business overview 297
14.1.11.2 Products offered 297
14.1.11.3 Recent developments 298
14.1.11.3.1 Product launches 298
14.1.11.3.2 Deals 298
14.1.11.3.3 Expansions 299
14.1.12 GYMNA INTERNATIONAL 300
14.1.12.1 Business overview 300
14.1.12.2 Products offered 300
14.1.12.3 Recent developments 301
14.1.12.3.1 Product launches 301
14.1.13 ASTAR 302
14.1.13.1 Business overview 302
14.1.13.2 Products offered 302
14.1.14 PHYSIOMED ELEKTROMEDIZIN AG (FORMERLY PROXOMED) 304
14.1.14.1 Business overview 304
14.1.14.2 Products offered 304
14.1.15 TACTILE MEDICAL 307
14.1.15.1 Business overview 307
14.1.15.2 Products offered 308
14.1.15.3 Recent developments 308
14.1.15.3.1 Product launches 308
14.1.16 DIH MEDICAL 309
14.1.16.1 Business overview 309
14.1.16.2 Products offered 310
14.1.16.3 Recent developments 311
14.1.16.3.1 Product launches 311
14.1.16.3.2 Deals 311
14.1.16.3.3 Other developments 312
14.1.17 TECHNOGYM SPA 313
14.1.17.1 Business overview 313
14.1.17.2 Products offered 314
14.1.17.3 Recent developments 315
14.1.17.3.1 Expansions 315
14.1.18 OMRON CORPORATION 316
14.1.18.1 Business overview 316
14.1.18.2 Products offered 317
14.1.19 OG WELLNESS TECHNOLOGIES CO., LTD. 318
14.1.19.1 Business overview 318
14.1.19.2 Products offered 318
14.1.19.3 Recent developments 320
14.1.19.3.1 Deals 320
14.1.20 GUANGZHOU LONGEST MEDICAL TECHNOLOGY CO., LTD. 321
14.1.20.1 Business overview 321
14.1.20.2 Products offered 321
14.1.20.3 Recent developments 322
14.1.20.3.1 Product approvals & launches 322
14.2 OTHER PLAYERS 324
14.2.1 KINVENT 324
14.2.2 EXOATLET 325
14.2.3 MANAMED 326
14.2.4 BEABLE HEALTH PVT. LTD. 327
14.2.5 BALANCE METRIX 328
15 RESEARCH METHODOLOGY 329
15.1 RESEARCH APPROACH 329
15.1.1 SECONDARY DATA 330
15.1.1.1 Key data from secondary sources 331
15.1.2 PRIMARY DATA 331
15.1.2.1 Key data from primary sources 332
15.1.2.2 Key industry insights 333
15.2 MARKET SIZE ESTIMATION 333
15.2.1 BOTTOM-UP APPROACH 333
15.2.2 TOP-DOWN APPROACH 334
15.2.3 BASE NUMBER ESTIMATION 334
15.3 MARKET FORECAST APPROACH 336
15.4 MARKET BREAKDOWN & DATA TRIANGULATION 338
15.5 RESEARCH ASSUMPTIONS 339
15.6 FACTOR ANALYSIS 339
15.7 RESEARCH LIMITATIONS 340
15.7.1 METHODOLOGY-RELATED LIMITATIONS 340
15.7.2 SCOPE-RELATED LIMITATIONS 340
15.8 RISK ASSESSMENT 340
16 APPENDIX 341
16.1 DISCUSSION GUIDE 341
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 345
16.3 CUSTOMIZATION OPTIONS 347
16.4 RELATED REPORTS 347
16.5 AUTHOR DETAILS 348

ページTOPに戻る

List of Tables/Graphs

TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 32.
TABLE 2 GROWTH RATE IN GERIATRIC POPULATION, BY REGION, 2020 VS. 2050 44.
TABLE 3 PER CAPITA NATIONAL INCOME (USD) 48.
TABLE 4 PHYSIOTHERAPY EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 54.
TABLE 5 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021–2030 56.
TABLE 6 PHYSIOTHERAPY EQUIPMENT MARKET: ROLE IN ECOSYSTEM 62.
TABLE 7 AVERAGE SELLING PRICE OF PHYSIOTHERAPY EQUIPMENT, BY PRODUCT, 2025 (USD) 63.
TABLE 8 AVERAGE SELLING PRICE OF ELECTROTHERAPY EQUIPMENT, BY REGION, 2023–2025 (USD) 64.
TABLE 9 AVERAGE SELLING PRICE OF ULTRASOUND EQUIPMENT, BY REGION, 2023–2025 (USD) 64.
TABLE 10 AVERAGE SELLING PRICE OF CRYOTHERAPY EQUIPMENT, BY REGION, 2023–2025 (USD) 64.
TABLE 11 AVERAGE SELLING PRICE OF HEAT THERAPY EQUIPMENT, BY REGION, 2023–2025 (USD) 65.
TABLE 12 IMPORT DATA FOR PHYSIOTHERAPY EQUIPMENT (HS CODE: 9019), BY COUNTRY, 2021–2025 (USD THOUSAND) 65.
TABLE 13 EXPORT DATA FOR PHYSIOTHERAPY EQUIPMENT (HS CODE: 9019), BY COUNTRY, 2021–2025 (USD THOUSAND) 66.
TABLE 14 PHYSIOTHERAPY EQUIPMENT MARKET: LIST OF KEY CONFERENCES & EVENTS, 2026–2027 66.
TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES 71.
TABLE 16 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR PHYSIOTHERAPY EQUIPMENT 72.
TABLE 17 PHYSIOTHERAPY EQUIPMENT MARKET: LIST OF MAJOR PATENTS 78.
TABLE 18 TOP USE CASES & MARKET POTENTIAL 80.
TABLE 19 PHYSIOTHERAPY EQUIPMENT MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION 81.
TABLE 20 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS 82.
TABLE 21 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85.
TABLE 22 US: REGULATORY PROCESS FOR MEDICAL DEVICES 86.
TABLE 23 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES 87.
TABLE 24 CHINA: NATIONAL MEDICAL PRODUCTS ADMINISTRATION MEDICAL DEVICES CLASSIFICATION 88.
TABLE 25 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF END USERS 91.
TABLE 26 KEY BUYING CRITERIA FOR END USERS 92.
TABLE 27 ADOPTION BARRIERS & INTERNAL CHALLENGES 92.
TABLE 28 PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 97.
TABLE 29 PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 98.
TABLE 30 ELECTROTHERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS 99.
TABLE 31 ELECTROTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 100.
TABLE 32 ELECTROTHERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS) 101.
TABLE 33 ULTRASOUND EQUIPMENT OFFERED BY KEY MARKET PLAYERS 102.
TABLE 34 ULTRASOUND EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 103.
TABLE 35 ULTRASOUND EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS) 104.
TABLE 36 EXERCISE THERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS 105.
TABLE 37 EXERCISE THERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 106.
TABLE 38 HEAT THERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS 107.
TABLE 39 HEAT THERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 108.
TABLE 40 HEAT THERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS) 109.
TABLE 41 CRYOTHERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS 110.
TABLE 42 CRYOTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 111.
TABLE 43 CRYOTHERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS) 112.
TABLE 44 COMBINATION THERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS 113.
TABLE 45 COMBINATION THERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 113.
TABLE 46 COMBINATION THERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS) 114.
TABLE 47 CONTINUOUS PASSIVE MOTION THERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS 115.
TABLE 48 CONTINUOUS PASSIVE MOTION THERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 115.
TABLE 49 CONTINUOUS PASSIVE MOTION THERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS) 116.
TABLE 50 SHOCKWAVE THERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS 117.
TABLE 51 SHOCKWAVE THERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 118.
TABLE 52 SHOCKWAVE THERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS) 119.
TABLE 53 LASER THERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS 120.
TABLE 54 LASER THERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 121.
TABLE 55 LASER THERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS) 122.
TABLE 56 TRACTION THERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS 123.
TABLE 57 TRACTION THERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 124.
TABLE 58 TRACTION THERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS) 125.
TABLE 59 MAGNETIC PRESSURE THERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS 126.
TABLE 60 MAGNETIC PRESSURE THERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127.
TABLE 61 MAGNETIC PRESSURE THERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS) 128.
TABLE 62 OTHER PHYSIOTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 129.
TABLE 63 PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 130.
TABLE 64 PHYSIOTHERAPY ACCESSORIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 130.
TABLE 65 PHYSIOTHERAPY FURNITURE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 131.
TABLE 66 OTHER ACCESSORIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132.
TABLE 67 PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 134.
TABLE 68 PHYSIOTHERAPY EQUIPMENT MARKET FOR MUSCULOSKELETAL & ORTHOPEDIC REHABILITATION APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 135.
TABLE 69 PHYSIOTHERAPY EQUIPMENT MARKET FOR NEUROLOGICAL REHABILITATION APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 137.
TABLE 70 PHYSIOTHERAPY EQUIPMENT MARKET FOR CARDIOVASCULAR & PULMONARY REHABILITATION APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 139.
TABLE 71 PHYSIOTHERAPY EQUIPMENT MARKET FOR SPORTS REHABILITATION APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 140.
TABLE 72 PHYSIOTHERAPY EQUIPMENT MARKET FOR PELVIC HEALTH & UROGYNECOLOGICAL REHABILITATION APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 142.
TABLE 73 PHYSIOTHERAPY EQUIPMENT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 143.
TABLE 74 PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 145.
TABLE 75 PHYSIOTHERAPY EQUIPMENT MARKET FOR PHYSIOTHERAPY & REHABILITATION CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 146.
TABLE 76 PHYSIOTHERAPY EQUIPMENT MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION) 147.
TABLE 77 PHYSIOTHERAPY EQUIPMENT MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION) 149.
TABLE 78 PHYSIOTHERAPY EQUIPMENT MARKET FOR PHYSICIANS’ OFFICES, BY COUNTRY, 2024–2031 (USD MILLION) 150.
TABLE 79 PHYSIOTHERAPY EQUIPMENT MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 151.
TABLE 80 PHYSIOTHERAPY EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 154.
TABLE 81 NORTH AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 156.
TABLE 82 NORTH AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 156.
TABLE 83 NORTH AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 157.
TABLE 84 NORTH AMERICA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 157.
TABLE 85 NORTH AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 158.
TABLE 86 NORTH AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 158.
TABLE 87 US: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 159.
TABLE 88 US: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 160.
TABLE 89 US: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 160.
TABLE 90 US: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 161.
TABLE 91 US: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2 024–2031 (USD MILLION) 161.
TABLE 92 CANADA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 162.
TABLE 93 CANADA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 162.
TABLE 94 CANADA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 163.
TABLE 95 CANADA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 163.
TABLE 96 CANADA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 163.
TABLE 97 EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 165.
TABLE 98 EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 165.
TABLE 99 EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 166.
TABLE 100 EUROPE: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 166.
TABLE 101 EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 167.
TABLE 102 EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 167.
TABLE 103 GERMANY: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 168.
TABLE 104 GERMANY: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 168.
TABLE 105 GERMANY: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 169.
TABLE 106 GERMANY: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 169.
TABLE 107 GERMANY: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 169.
TABLE 108 UK: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 170.
TABLE 109 UK: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 171.
TABLE 110 UK: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 171.
TABLE 111 UK: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 172.
TABLE 112 UK: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 172.
TABLE 113 FRANCE: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 173.
TABLE 114 FRANCE: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 173.
TABLE 115 FRANCE: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 174.
TABLE 116 FRANCE: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 174.
TABLE 117 FRANCE: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 174.
TABLE 118 ITALY: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 175.
TABLE 119 ITALY: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 176.
TABLE 120 ITALY: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 176.
TABLE 121 ITALY: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 177.
TABLE 122 ITALY: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 177.
TABLE 123 SPAIN: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 178.
TABLE 124 SPAIN: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 178.
TABLE 125 SPAIN: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 179.
TABLE 126 SPAIN: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 179.
TABLE 127 SPAIN: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 179.
TABLE 128 REST OF EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 180.
TABLE 129 REST OF EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 180.
TABLE 130 REST OF EUROPE: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 181.
TABLE 131 REST OF EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 181.
TABLE 132 REST OF EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 181.
TABLE 133 ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 183.
TABLE 134 ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 183.
TABLE 135 ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 184.
TABLE 136 ASIA PACIFIC: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 184.
TABLE 137 ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 185.
TABLE 138 ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 185.
TABLE 139 JAPAN: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 186.
TABLE 140 JAPAN: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 186.
TABLE 141 JAPAN: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 187.
TABLE 142 JAPAN: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 187.
TABLE 143 JAPAN: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 187.
TABLE 144 CHINA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 188.
TABLE 145 CHINA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 189.
TABLE 146 CHINA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 189.
TABLE 147 CHINA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 190.
TABLE 148 CHINA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 190.
TABLE 149 INDIA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 191.
TABLE 150 INDIA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 191.
TABLE 151 INDIA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 192.
TABLE 152 INDIA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 192.
TABLE 153 INDIA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 192.
TABLE 154 AUSTRALIA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 193.
TABLE 155 AUSTRALIA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 194.
TABLE 156 AUSTRALIA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 194.
TABLE 157 AUSTRALIA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 195.
TABLE 158 AUSTRALIA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 195.
TABLE 159 SOUTH KOREA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 196.
TABLE 160 SOUTH KOREA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 196.
TABLE 161 SOUTH KOREA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 197.
TABLE 162 SOUTH KOREA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 197.
TABLE 163 SOUTH KOREA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 197.
TABLE 164 REST OF ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 198.
TABLE 165 REST OF ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 199.
TABLE 166 REST OF ASIA PACIFIC: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 199.
TABLE 167 REST OF ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 200.
TABLE 168 REST OF ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 200.
TABLE 169 LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 201.
TABLE 170 LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 201.
TABLE 171 LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 202.
TABLE 172 LATIN AMERICA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 202.
TABLE 173 LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 203.
TABLE 174 LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 203.
TABLE 175 BRAZIL: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 204.
TABLE 176 BRAZIL: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 205.
TABLE 177 BRAZIL: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 205.
TABLE 178 BRAZIL: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 206.
TABLE 179 BRAZIL: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 206.
TABLE 180 MEXICO: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 207.
TABLE 181 MEXICO: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 207.
TABLE 182 MEXICO: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 208.
TABLE 183 MEXICO: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 208.
TABLE 184 MEXICO: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 208.
TABLE 185 ARGENTINA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 209.
TABLE 186 ARGENTINA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 209.
TABLE 187 ARGENTINA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 210.
TABLE 188 ARGENTINA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 210.
TABLE 189 ARGENTINA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 210.
TABLE 190 REST OF LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 211.
TABLE 191 REST OF LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 211.
TABLE 192 REST OF LATIN AMERICA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 212.
TABLE 193 REST OF LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 212.
TABLE 194 REST OF LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 212.
TABLE 195 MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 214.
TABLE 196 MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 214.
TABLE 197 MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 215.
TABLE 198 MIDDLE EAST & AFRICA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 215.
TABLE 199 MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 216.
TABLE 200 MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 216.
TABLE 201 GCC COUNTRIES: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 217.
TABLE 202 GCC COUNTRIES: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 218.
TABLE 203 GCC COUNTRIES: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 218.
TABLE 204 GCC COUNTRIES: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 219.
TABLE 205 GCC COUNTRIES: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 219.
TABLE 206 REST OF MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 220.
TABLE 207 REST OF MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 220.
TABLE 208 REST OF MIDDLE EAST & AFRICA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 221.
TABLE 209 REST OF MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 221.
TABLE 210 REST OF MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 221.
TABLE 211 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN PHYSIOTHERAPY EQUIPMENT MARKET 223.
TABLE 212 PHYSIOTHERAPY EQUIPMENT MARKET: REGION FOOTPRINT 230.
TABLE 213 PHYSIOTHERAPY EQUIPMENT MARKET: PRODUCT FOOTPRINT 231.
TABLE 214 PHYSIOTHERAPY EQUIPMENT MARKET: APPLICATION FOOTPRINT 232.
TABLE 215 PHYSIOTHERAPY EQUIPMENT MARKET: END-USER FOOTPRINT 233.
TABLE 216 PHYSIOTHERAPY EQUIPMENT MARKET: LIST OF KEY STARTUPS/SMES 236.
TABLE 217 PHYSIOTHERAPY EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 236.
TABLE 218 PHYSIOTHERAPY EQUIPMENT MARKET: PRODUCT LAUNCHES & APPROVALS, JULY 2022–JUNE 2026 239.
TABLE 219 PHYSIOTHERAPY EQUIPMENT MARKET: DEALS, JULY 2022–JUNE 2026 240.
TABLE 220 PHYSIOTHERAPY EQUIPMENT MARKET: EXPANSIONS, JULY 2022–JUNE 2026 243.
TABLE 221 PHYSIOTHERAPY EQUIPMENT MARKET: OTHER DEVELOPMENTS, JULY 2022–JUNE 2026 244.
TABLE 222 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION): COMPANY OVERVIEW 245.
TABLE 223 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION): PRODUCTS OFFERED 246.
TABLE 224 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION): PRODUCT LAUNCHES, JULY 2022–JUNE 2026 251.
TABLE 225 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION): DEALS, JULY 2022–JUNE 2026 252.
TABLE 226 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION): EXPANSIONS, JULY 2022– JUNE 2026 253.
TABLE 227 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION): OTHER DEVELOPMENTS, JULY 2022– JUNE 2026 253.
TABLE 228 ZIMMER MEDIZINSYSTEME GMBH: COMPANY OVERVIEW 255.
TABLE 229 ZIMMER MEDIZINSYSTEME GMBH: PRODUCTS OFFERED 255.
TABLE 230 ZIMMER MEDIZINSYSTEME GMBH: PRODUCT LAUNCHES, JULY 2022–JUNE 2026 256.
TABLE 231 ZIMMER MEDIZINSYSTEME GMBH: DEALS, JULY 2022–JUNE 2026 257.
TABLE 232 ZIMMER MEDIZINSYSTEME GMBH: OTHER DEVELOPMENTS, JULY 2022–JUNE 2026 257.
TABLE 233 ALTIVERA MEDICAL, INC. (FORMERLY ZYNEX, INC.): COMPANY OVERVIEW 259.
TABLE 234 ALTIVERA MEDICAL, INC. (FORMERLY ZYNEX, INC.): PRODUCTS OFFERED 260.
TABLE 235 ALTIVERA MEDICAL, INC. (FORMERLY ZYNEX, INC.): PRODUCT LAUNCHES & APPROVALS, JULY 2022–JUNE 2026 261.
TABLE 236 ALTIVERA MEDICAL, INC. (FORMERLY ZYNEX, INC.): DEALS, JULY 2022–JUNE 2026 262.
TABLE 237 ALTIVERA MEDICAL, INC. (FORMERLY ZYNEX, INC.): EXPANSIONS, JULY 2022–JUNE 2026 263.
TABLE 238 ALTIVERA MEDICAL, INC. (FORMERLY ZYNEX, INC.): OTHER DEVELOPMENTS, JULY 2022–JUNE 2026 263.
TABLE 239 PERFORMANCE HEALTH (SUBSIDIARY OF MADISON DEARBORN PARTNERS): COMPANY OVERVIEW 265.
TABLE 240 PERFORMANCE HEALTH (SUBSIDIARY OF MADISON DEARBORN PARTNERS): PRODUCTS OFFERED 265.
TABLE 241 PERFORMANCE HEALTH (SUBSIDIARY OF MADISON DEARBORN PARTNERS): PRODUCT LAUNCHES, JULY 2022–JUNE 2026 272.
TABLE 242 PERFORMANCE HEALTH (SUBSIDIARY OF MADISON DEARBORN PARTNERS): DEALS, JULY 2022–JUNE 2026 273.
TABLE 243 PERFORMANCE HEALTH (SUBSIDIARY OF MADISON DEARBORN PARTNERS): OTHER DEVELOPMENTS, JULY 2022–JUNE 2026 274.
TABLE 244 ITO CO., LTD.: COMPANY OVERVIEW 276.
TABLE 245 ITO CO., LTD.: PRODUCTS OFFERED 276.
TABLE 246 DYNATRONICS CORPORATION: COMPANY OVERVIEW 279.
TABLE 247 DYNATRONICS CORPORATION: PRODUCTS OFFERED 280.
TABLE 248 DYNATRONICS CORPORATION: PRODUCT LAUNCHES, APRIL 2022–JUNE 2026 282.
TABLE 249 DYNATRONICS CORPORATION: DEALS, JULY 2022–JUNE 2026 283.
TABLE 250 DYNATRONICS CORPORATION: OTHER DEVELOPMENTS, JULY 2022–JUNE 2026 283.
TABLE 251 BTL INDUSTRIES: COMPANY OVERVIEW 284.
TABLE 252 BTL INDUSTRIES: PRODUCTS OFFERED 284.
TABLE 253 BTL INDUSTRIES: PRODUCT LAUNCHES, JULY 2022–JUNE 2026 286.
TABLE 254 BTL INDUSTRIES: DEALS, JULY 2022–JUNE 2026 286.
TABLE 255 BTL INDUSTRIES: EXPANSIONS, JULY 2022–JUNE 2026 287.
TABLE 256 BTL INDUSTRIES: OTHER DEVELOPMENTS, JULY 2022–JUNE 2026 287.
TABLE 257 ENRAF-NONIUS B.V.: COMPANY OVERVIEW 288.
TABLE 258 ENRAF-NONIUS B.V.: PRODUCTS OFFERED 288.
TABLE 259 ENRAF-NONIUS B.V.: DEALS, JULY 2022–JUNE 2026 290.
TABLE 260 MECTRONIC MEDICALE: COMPANY OVERVIEW 291.
TABLE 261 MECTRONIC MEDICALE: PRODUCTS OFFERED 291.
TABLE 262 RICHMAR: COMPANY OVERVIEW 293.
TABLE 263 RICHMAR: PRODUCTS OFFERED 293.
TABLE 264 RICHMAR: PRODUCT LAUNCHES, JULY 2022–JUNE 2026 295.
TABLE 265 RICHMAR: DEALS, JULY 2022–JUNE 2026 296.
TABLE 266 STORZ MEDICAL AG: COMPANY OVERVIEW 297.
TABLE 267 STORZ MEDICAL AG: PRODUCTS OFFERED 297.
TABLE 268 STORZ MEDICAL AG: PRODUCT LAUNCHES, JULY 2022–SEPTEMBER 2024 298.
TABLE 269 STORZ MEDICAL AG: DEALS, JULY 2022–SEPTEMBER 2024 298.
TABLE 270 STORZ MEDICAL AG: EXPANSIONS, JULY 2022–SEPTEMBER 2024 299.
TABLE 271 GYMNA INTERNATIONAL: COMPANY OVERVIEW 300.
TABLE 272 GYMNA INTERNATIONAL: PRODUCTS OFFERED 300.
TABLE 273 GYMNA INTERNATIONAL: PRODUCT LAUNCHES, JULY 2022–SEPTEMBER 2024 301.
TABLE 274 ASTAR: COMPANY OVERVIEW 302.
TABLE 275 ASTAR: PRODUCTS OFFERED 302.
TABLE 276 PHYSIOMED ELEKTROMEDIZIN AG (FORMERLY PROXOMED): COMPANY OVERVIEW 304.
TABLE 277 PHYSIOMED ELEKTROMEDIZIN AG (FORMERLY PROXOMED): PRODUCTS OFFERED 304.
TABLE 278 TACTILE MEDICAL: COMPANY OVERVIEW 307.
TABLE 279 TACTILE MEDICAL: PRODUCTS OFFERED 308.
TABLE 280 TACTILE MEDICAL: PRODUCT LAUNCHES, JULY 2022–JUNE 2026 308.
TABLE 281 DIH MEDICAL: COMPANY OVERVIEW 309.
TABLE 282 DIH MEDICAL: PRODUCTS OFFERED 310.
TABLE 283 DIH MEDICAL: PRODUCT LAUNCHES, JULY 2022–JUNE 2026 311.
TABLE 284 DIH MEDICAL: DEALS, JULY 2022–JUNE 2026 311.
TABLE 285 DIH MEDICAL: OTHER DEVELOPMENTS, JULY 2022–JUNE 2026 312.
TABLE 286 TECHNOGYM SPA: COMPANY OVERVIEW 313.
TABLE 287 TECHNOGYM SPA: PRODUCTS OFFERED 314.
TABLE 288 TECHNOGYM SPA: EXPANSIONS, JULY 2022–JUNE 2026 315.
TABLE 289 OMRON CORPORATION: COMPANY OVERVIEW 316.
TABLE 290 OMRON CORPORATION: PRODUCTS OFFERED 317.
TABLE 291 OG WELLNESS TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW 318.
TABLE 292 OG WELLNESS TECHNOLOGIES CO., LTD.: PRODUCTS OFFERED 318.
TABLE 293 OG WELLNESS TECHNOLOGIES CO., LTD.: DEALS, JULY 2022–JUNE 2026 320.
TABLE 294 GUANGZHOU LONGEST MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 321.
TABLE 295 GUANGZHOU LONGEST MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED 321.
TABLE 296 GUANGZHOU LONGEST MEDICAL TECHNOLOGY CO., LTD.: PRODUCT APPROVALS & LAUNCHES, JULY 2022–JUNE 2026 322.
TABLE 297 RISK ASSESSMENT: PHYSIOTHERAPY EQUIPMENT MARKET 340.
FIGURE 1 PHYSIOTHERAPY EQUIPMENT MARKET SEGMENTATION & REGIONAL SCOPE 30.
FIGURE 2 KEY INSIGHTS & MARKET HIGHLIGHTS 34.
FIGURE 3 PHYSIOTHERAPY EQUIPMENT MARKET, 2024–2031 (USD MILLION) 35.
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PHYSIOTHERAPY EQUIPMENT MARKET 35.
FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF PHYSIOTHERAPY EQUIPMENT MARKET 36.
FIGURE 6 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN PHYSIOTHERAPY EQUIPMENT MARKET, 2025 37.
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 38.
FIGURE 8 RISING GERIATRIC POPULATION AND INCREASING CHRONIC DISEASES TO DRIVE MARKET 39.
FIGURE 9 PHYSIOTHERAPY & REHABILITATION CENTERS AND JAPAN ACCOUNTED FOR LARGEST MARKET SHARE IN 2025 40.
FIGURE 10 CHINA TO REGISTER FASTEST GROWTH DURING FORECAST PERIOD 41.
FIGURE 11 EUROPE TO DOMINATE MARKET IN 2031 42.
FIGURE 12 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 42.
FIGURE 13 PHYSIOTHERAPY EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 43.
FIGURE 14 PHYSIOTHERAPY EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 54.
FIGURE 15 PHYSIOTHERAPY EQUIPMENT MARKET: SUPPLY CHAIN ANALYSIS 60.
FIGURE 16 PHYSIOTHERAPY EQUIPMENT MARKET: VALUE CHAIN ANALYSIS 61.
FIGURE 17 PHYSIOTHERAPY EQUIPMENT MARKET: ECOSYSTEM ANALYSIS 62.
FIGURE 18 PHYSIOTHERAPY EQUIPMENT MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 67.
FIGURE 19 INVESTMENT/VENTURE CAPITAL SCENARIO IN PHYSIOTHERAPY EQUIPMENT MARKET, 2022–2025 70.
FIGURE 20 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) IN PHYSIOTHERAPY EQUIPMENT (JANUARY 2015–DECEMBER 2025) 77.
FIGURE 21 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR PHYSIOTHERAPY EQUIPMENT PATENTS, 2015–2025 78.
FIGURE 22 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF PHYSIOTHERAPY PRODUCT END USERS 91.
FIGURE 23 KEY BUYING CRITERIA FOR END USERS 91.
FIGURE 24 PHYSIOTHERAPY EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 153.
FIGURE 25 NORTH AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET SNAPSHOT 155.
FIGURE 26 ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET SNAPSHOT 182.
FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN PHYSIOTHERAPY EQUIPMENT MARKET (2021–2025) 225.
FIGURE 28 PHYSIOTHERAPY EQUIPMENT MARKET RANKING, BY KEY PLAYERS (2025) 226.
FIGURE 29 PHYSIOTHERAPY EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 228.
FIGURE 30 PHYSIOTHERAPY EQUIPMENT MARKET: COMPANY FOOTPRINT 229.
FIGURE 31 PHYSIOTHERAPY EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 235.
FIGURE 32 PHYSIOTHERAPY EQUIPMENT MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 237.
FIGURE 33 EV/EBITDA OF KEY VENDORS 238.
FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 238.
FIGURE 35 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION): COMPANY SNAPSHOT (2025) 246.
FIGURE 36 ZYNEX, INC.: COMPANY SNAPSHOT (2024) 260.
FIGURE 37 DYNATRONICS CORPORATION: COMPANY SNAPSHOT (2025) 280.
FIGURE 38 TACTILE MEDICAL: COMPANY SNAPSHOT (2025) 307.
FIGURE 39 DIH MEDICAL: COMPANY SNAPSHOT (2024) 310.
FIGURE 40 TECHNOGYM SPA: COMPANY SNAPSHOT (2025) 314.
FIGURE 41 OMRON CORPORATION: COMPANY SNAPSHOT (2025) 317.
FIGURE 42 RESEARCH DESIGN 329.
FIGURE 43 PRIMARY SOURCES 332.
FIGURE 44 BOTTOM-UP APPROACH 333.
FIGURE 45 TOP-DOWN APPROACH 334.
FIGURE 46 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 335.
FIGURE 47 MARKET SIZE ESTIMATION: DEMAND-SIDE ANALYSIS 336.
FIGURE 48 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 337.
FIGURE 49 MARKET DATA TRIANGULATION METHODOLOGY 338.